Clinical Supply Clinical Trials Pharmacokinetics 
The Pharma Data
DECEMBER 14, 2020
The trial, which will explore the pharmacokinetics and safety of ATX01 in healthy volunteers, is due to start in January 2021. AlgoTherapeutix recently raised a 12M€ Series A that will fund the Phase 1 and 2 clinical development of ATX01.
The Pharma Data
NOVEMBER 22, 2020
“In collaboration with our partner, Novartis, our team continues to move at extraordinary speed from idea to bench to clinical trials, driven by a common desire to help patients against this devastating disease and help bring the world back closer to normalcy.” Chief Medical Officer of Molecular Partners.
Expert insights. Personalized for you.
52 
Let's personalize your content